Cargando…

Public health impact of low-dose aspirin on colorectal cancer, cardiovascular disease and safety in the UK – Results from micro-simulation model()

BACKGROUND: Low-dose aspirin therapy reduces the risk of cardiovascular disease and may have a positive effect on the prevention of colorectal cancer. We evaluated the population-level expected effect of regular low-dose aspirin use on cardiovascular disease (CVD), colorectal cancer (CRC), gastroint...

Descripción completa

Detalles Bibliográficos
Autores principales:	Biccler, Jorne, Bollaerts, Kaatje, Vora, Pareen, Sole, Elodie, Rodriguez, Luis Alberto Garcia, Lanas, Angel, Langley, Ruth E., Gabarró, Montse Soriano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350404/ https://www.ncbi.nlm.nih.gov/pubmed/34401469 http://dx.doi.org/10.1016/j.ijcha.2021.100851

Ejemplares similares

Effect of Proton Pump Inhibitors on Risks of Upper and Lower Gastrointestinal Bleeding among Users of Low-Dose Aspirin: A Population-Based Observational Study
por: García Rodríguez, Luis A., et al.
Publicado: (2020)

Association Between Low-Dose Aspirin Use and Colorectal Cancer Incidence in Taiwan
por: Lin, Hui-Min Diana, et al.
Publicado: (2020)

Long-Term Adherence and Persistence to Low-Dose Aspirin for the Prevention of Cardiovascular Disease: A Population-Based Cohort Study
por: Vora, Pareen, et al.
Publicado: (2022)

New use of low-dose aspirin and risk of colorectal cancer by stage at diagnosis: a nested case–control study in UK general practice
por: García Rodríguez, Luis A., et al.
Publicado: (2017)

Low‐dose aspirin and risk of gastric and oesophageal cancer: A population‐based study in the United Kingdom using The Health Improvement Network
por: García Rodríguez, Luis A., et al.
Publicado: (2020)

Patient Preferences of Low-Dose Aspirin for Cardiovascular Disease and Colorectal Cancer Prevention in Italy: A Latent Class Analysis
por: Tervonen, Tommi, et al.
Publicado: (2021)

Limited evidence on persistence with anticoagulants, and its effect on the risk of recurrence of venous thromboembolism: a systematic review of observational studies
por: Vora, Pareen, et al.
Publicado: (2016)

Low-dose aspirin and risk of upper/lower gastrointestinal bleeding by bleed severity: a cohort study with nested case-control analysis using primary care electronic health records from the United Kingdom
por: García Rodríguez, Luis A., et al.
Publicado: (2019)

A review of studies evaluating the effectiveness of risk minimisation measures in Europe using the European Union electronic Register of Post‐Authorization Studies
por: Vora, Pareen, et al.
Publicado: (2018)

The Protective Effect of Low-Dose Aspirin against Colorectal Cancer Is Unlikely Explained by Selection Bias: Results from Three Different Study Designs in Clinical Practice
por: Cea Soriano, Lucía, et al.
Publicado: (2016)

Validation of low‐dose aspirin prescription data in The Health Improvement Network: how much misclassification due to over‐the‐counter use?
por: Cea Soriano, Lucía, et al.
Publicado: (2015)

Safety and effectiveness of low-dose aspirin for the prevention of gastrointestinal cancer in adults without atherosclerotic cardiovascular disease: a population-based cohort study
por: Shami, Jessica J P, et al.
Publicado: (2022)

Aspirin in the 21st century—common mechanisms of disease and their modulation by aspirin: a report from the 2015 scientific conference of the international aspirin foundation, 28 August, London, UK
por: Smith, Tom, et al.
Publicado: (2015)

Validity and completeness of colorectal cancer diagnoses in a primary care database in the United Kingdom
por: Cea Soriano, Lucía, et al.
Publicado: (2015)

Trends in the contemporary incidence of colorectal cancer and patient characteristics in the United Kingdom: a population-based cohort study using The Health Improvement Network
por: Soriano, Lucía Cea, et al.
Publicado: (2018)

Aspirin and Colorectal Cancer Prevention and Treatment: Is It for Everyone?
por: Coyle, Christopher, et al.
Publicado: (2016)

Trends in the use of oral anticoagulants, antiplatelets and statins in four European countries: a population-based study
por: García Rodríguez, Luis A., et al.
Publicado: (2021)

The reporting and diagnosis of uterine fibroids in the UK: an observational study
por: Martín-Merino, Elisa, et al.
Publicado: (2016)

Improved benchmark-multiplier method to estimate the prevalence of ever-injecting drug use in Belgium, 2000–10
por: Bollaerts, Kaatje, et al.
Publicado: (2013)

Risk factors for modified vaccine effectiveness of the live attenuated zoster vaccine among the elderly in England()
por: Bollaerts, Kaatje, et al.
Publicado: (2019)

Clinical evidence for the use of aspirin in the treatment of cancer
por: Langley, Ruth E
Publicado: (2013)

Highlights from the 2019 International Aspirin Foundation Scientific Conference, Rome, 28 June 2019: benefits and risks of antithrombotic therapy for cardiovascular disease prevention
por: Walker, Jaqui, et al.
Publicado: (2020)

Preventing infectious diseases for healthy ageing: The VITAL public-private partnership project
por: Van Baarle, Debbie, et al.
Publicado: (2020)

Estimating the loss of lifetime function using flexible parametric relative survival models
por: Jakobsen, Lasse H., et al.
Publicado: (2019)

Gastrointestinal Safety of Aspirin for a High-Dose, Multiple-Day Treatment Regimen: A Meta-Analysis of Three Randomized Controlled Trials
por: Forder, Samantha, et al.
Publicado: (2016)

The Aspirin Foundation Scientific Conference: the history, the present state and the future of aspirin prophylaxis
por: Smith, Tom, et al.
Publicado: (2014)

Prophylactic Aspirin and Public
por: Morgan, Gareth
Publicado: (2013)

Aspirin and colorectal cancer.
por: La Vecchia, C., et al.
Publicado: (1997)

Meningococcal disease in Asia: an under-recognized public health burden
por: VYSE, A., et al.
Publicado: (2011)

Benefit–Risk Monitoring of Vaccines Using an Interactive Dashboard: A Methodological Proposal from the ADVANCE Project
por: Bollaerts, Kaatje, et al.
Publicado: (2018)

Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy?
por: Langley, R E, et al.
Publicado: (2011)

Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC)
por: Arlegui, Hugo, et al.
Publicado: (2020)

The role of aspirin in the prevention of ovarian, endometrial and cervical cancers
por: Joharatnam-Hogan, Nalinie, et al.
Publicado: (2020)

Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care
por: García Rodríguez, Luis A, et al.
Publicado: (2011)

Comparison of gastrointestinal adverse events between fast release tablets and regular acetylsalicylic acid (aspirin) galenics after short-term use: a meta-analysis of randomized clinical trials
por: Lanas, Angel, et al.
Publicado: (2023)

Overall survival and second primary malignancies in men with metastatic prostate cancer
por: Mehtälä, Juha, et al.
Publicado: (2020)

Disease misclassification in electronic healthcare database studies: Deriving validity indices—A contribution from the ADVANCE project
por: Bollaerts, Kaatje, et al.
Publicado: (2020)

Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies
por: García Rodríguez, Luis A., et al.
Publicado: (2016)

The global epidemiology of upper and lower gastrointestinal bleeding in general population: A systematic review
por: Saydam, Şiir Su, et al.
Publicado: (2023)

Bias due to differential and non-differential disease- and exposure misclassification in studies of vaccine effectiveness
por: De Smedt, Tom, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4k3tgqeulcr6alf99c3h9h5gao